No Adverse Event; Revaccination with different Covid-19 vaccine; Interchange of vaccine products; nurse give a vaccine from a syringe that was expired yesterday, Dose administered greater than 12(US)hours post puncture; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 IMMUNISATION (Revaccination with different Covid-19 vaccine), INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products), EXPIRED PRODUCT ADMINISTERED (nurse give a vaccine from a syringe that was expired yesterday, Dose administered greater than 12(US)hours post puncture) and NO ADVERSE EVENT (No Adverse Event) in a 77-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 019H22A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (Dose 2) and PFIZER BIONTECH COVID-19 VACCINE (Dose 1). Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.    On 13-Dec-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 13-Dec-2022, the patient experienced COVID-19 IMMUNISATION (Revaccination with different Covid-19 vaccine), INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) and EXPIRED PRODUCT ADMINISTERED (nurse give a vaccine from a syringe that was expired yesterday, Dose administered greater than 12(US)hours post puncture). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse Event). At the time of the report, COVID-19 IMMUNISATION (Revaccination with different Covid-19 vaccine), INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products), EXPIRED PRODUCT ADMINISTERED (nurse give a vaccine from a syringe that was expired yesterday, Dose administered greater than 12(US)hours post puncture) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessments were provided for COVID-19 IMMUNISATION (Revaccination with different Covid-19 vaccine), INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) and EXPIRED PRODUCT ADMINISTERED (nurse give a vaccine from a syringe that was expired yesterday, Dose administered greater than 12(US)hours post puncture).    No Concomitant medications were provided.  It was unknown whether patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  It was reported that patient had received Pfizer twice and then two booster doses of Moderna monovalent and this was the first Moderna Bivalent booster. HCP had a nurse give a vaccine from a syringe that was expired yesterday. Dose administered greater than 12(US) hours post puncture  1 Individual vial  was involved with size of 2.5 mL  Vial was initially stored in the refrigerator on 30 Nov 2022 and was first punctured on 12 Dec 2022 at 12:30 PM and was administered on 13 Dec 2022 at 11:25 AM. Vial was stored at RT post puncture and did not undergo any temperature excursions. Total amount of time the vial was exposed to room temperature range (8 degree to 25 degree C which was equal to 46 degree to 77 degree F) was Just under 24 hours. About 23 hours.  No treatment medications were provided.